Jiangsu, China

Wang Zhang

This inventor holds 7 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Legend Biotech Ireland Limited, Nanjing Legend Biotech Co., Ltd., Nanjing Genscript Biotech Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wang Zhang. Retrieved from https://idiyas.com/inventor/wang-zhang-wml70pw0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jiangsu, CN (2024)
  • Nanjing, CN (2024)

Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Inventor Wang Zhang

Introduction

Wang Zhang, an accomplished inventor based in Jiangsu, China, is known for his impactful contributions to the field of biomedicine. With a total of four patents to his name, he has developed innovative technologies that hold promise for advancements in cancer treatment.

Latest Patents

Among Wang Zhang's latest patents is the development of single-domain antibodies against CLL1 and constructs thereof. This invention focuses on single-domain antibodies that specifically target CLL1, along with engineered immune effector cells such as T cells. These innovations include chimeric receptors and immune engagers, which provide new methods for treating cancer through advanced pharmaceutical compositions and kits.

Another significant patent is his creation of a fusion protein dimer utilizing an antibody Fc region as a backbone. This invention comprises a unique combination of two polypeptide chains that incorporate single-domain antibodies and cytokines fused to the Fc regions. The fusion protein dimer enhances the activity of single-domain antibodies while improving the biological activity of cytokines, thus presenting a promising avenue for immunotherapeutic drugs aimed at tumor treatment. The innovative design effectively enhances targeted transport and reduces cytotoxic effects, leading to improved anti-tumor potential.

Career Highlights

Wang Zhang has had a fruitful career and has worked with renowned companies including Nanjing Legend Biotech Co., Ltd. and Legend Biotech Ireland Limited. His work in these organizations has been instrumental in developing cutting-edge biotechnologies that address critical health challenges, particularly in oncology.

Collaborations

Throughout his professional journey, Wang Zhang has collaborated with notable peers such as Shu Wu and Yafeng Zhang. These partnerships have fostered an environment of innovation and advancement in the biomedicine field, enabling the exploration of various therapeutic strategies and technologies.

Conclusion

Wang Zhang's contributions to the field of biomedicine through his innovative patents have set a foundation for future developments in cancer therapies. His collaborative endeavors further enhance the potential for breakthrough inventions that may redefine treatment methodologies. As the field of biotechnology continues to evolve, Zhang stands out as a visionary inventor making significant strides toward improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…